logo-loader
viewZelda Therapeutics Ltd

Zelda Therapeutics ready to test 'entourage effect' hypothesis in cancer research

Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) executive chairman Harry Karelis tells Proactive Investors the medical cannabis researcher's latest news.

Initial results from a paediatric brain cancer study being conducted with the Telethon Kids Institute in Perth have validated that two chemicals naturally occurring in the cannabis plant, THC and CBD, each have some anti-cancer effects. Zelda Therapeutics will now aim to enhance that anti-cancer response by testing various chemical formulations.

“Cannabis seems to be quite a versatile therapeutic. It can treat a range of conditions, but it’s not the same cannabis for every condition; it’s this interplay between these THC and CBD molecules… taking the plant as our platform and then knowing how to mix and match these cannabinoids - what ratios, how much, how to give it, went to give it - means that we can target a whole range of indications from cancer to autism… The next phase in this brain cancer research is really comparing the results from our whole plant extracts versus the pure THC and pure CBD results which we announced,” Karelis explains.

“We’ve alluded to a pipeline of new opportunities that are coming through, and we’re reasonably close to finalising a new research program in a fairly important medical area, and we’re looking forward to finalising that in the coming weeks,” teases Karelis.

A new managing director, Dr Richard Hopkins, will be joining the team in July.

Quick facts: Zelda Therapeutics Ltd

Price: 0.072 AUD

ASX:ZLD
Market: ASX
Market Cap: $54.64 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zelda Therapeutics Ltd named herein, including the promotion by the Company of Zelda Therapeutics Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Ilera Healthcare deal is 'one piece of the puzzle' for Zelda Therapeutics in...

Zelda Therapeutics Ltd (ASX:ZLD, OTCBB:ZLDAF) managing director Dr Richard Hopkins speaks to Proactive Investors about the medical cannabis researcher's binding heads of agreement (HoA) with US-based medicinal cannabis company Ilera Healthcare LLC. The deal complements a number of...

on 03/12/2019

2 min read